2,2'-azobis(2-amidinopropane) has been researched along with Diabetes Mellitus, Type 2 in 3 studies
2,2'-azobis(2-amidinopropane): water-soluble free-radical initiator
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roche, M | 1 |
| Tarnus, E | 1 |
| Rondeau, P | 1 |
| Bourdon, E | 1 |
| Nagasaka, Y | 1 |
| Kaku, K | 1 |
| Nakamura, K | 1 |
| Kaneko, T | 1 |
| Haffner, SM | 1 |
| Agil, A | 1 |
| Mykkanen, L | 1 |
| Stern, MP | 1 |
| Jialal, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Diabetes and Cardiovascular Risk In Mexico City (San Antonio Heart Study)[NCT00005146] | 0 participants | Observational | 1979-05-31 | Completed | |||
| Incidence of Diabetes and Cardiovascular Disease in Mexican Americans[NCT00005205] | 0 participants | Observational | 1987-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for 2,2'-azobis(2-amidinopropane) and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effects of nutritional antioxidants on AAPH- or AGEs-induced oxidative stress in human SW872 liposarcoma cells.
Topics: Adipocytes; Amidines; Animals; Antioxidants; Ascorbic Acid; Caffeic Acids; Cattle; Cell Line; Cell P | 2009 |
The new oral hypoglycemic agent, CS-045, inhibits the lipid peroxidation of human plasma low density lipoprotein in vitro.
Topics: Administration, Oral; Amidines; Chromans; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Li | 1995 |
Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
Topics: Amidines; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; | 1995 |
Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
Topics: Amidines; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; | 1995 |
Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
Topics: Amidines; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; | 1995 |
Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
Topics: Amidines; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; | 1995 |